Results 191 to 200 of about 108,553 (222)

Pharmacogenomic profiling of the efficacy of gemcitabine monotherapy in metastatic pancreatic cancer: Subgroup analysis of the GENESECT study

open access: yesBritish Journal of Clinical Pharmacology, Volume 92, Issue 10, Page 3397-3406, October 2026.
Aim In the GENESECT study, no significant gemcitabine (GEM) metabolism‐related germline genetic polymorphisms (GPs) were identified because approximately 70% of patients received combination therapy with nab‐paclitaxel, which has metabolic pathways different from GEM.
Takashi Yokokawa   +21 more
wiley   +1 more source

Serum thiol redox-related alterations in asymptomatic first-degree relatives are associated with future Crohn's disease. [PDF]

open access: yesRedox Biol
Mu K   +19 more
europepmc   +1 more source

Upadacitinib for anti-TNFα refractory immune checkpoint inhibitor-induced colitis: a case report. [PDF]

open access: yesTher Adv Gastroenterol
Petrousis G   +5 more
europepmc   +1 more source

[Immunoglobulin G4-associated diseases of the digestive system--new problem in gastroenterology].

Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology, 2010
This review presents the latest information on new clinical and pathological syndrome in gastroenterology, forming the foundation of which is tissue infiltration of IgG4-positive plasma cells. Considered clinical variants of IgG4-associated diseases of the digestive system: IgG4-associated cholecystitis, holangita and autoimmune pancreatitis.
openaire   +1 more source

Potential role of irisin in digestive system diseases

Biomedicine and Pharmacotherapy, 2023
Huan Gao, Yanqing Song, Jinghui Zhai
exaly  

Home - About - Disclaimer - Privacy